News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Amneal Pharmaceuticals Appoints Dr. Shankar Hariharan as Chief Scientific Officer/EVP of Specialty Pharmaceuticals
July 9, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
HAUPPAUGE, N.Y.--(BUSINESS WIRE)--Amneal Pharmaceuticals is pleased to announce that Dr. Shankar Hariharan has joined the company as Chief Scientific Officer/Executive Vice President of Specialty Pharmaceuticals.
Twitter
LinkedIn
Facebook
Email
Print
People
Amneal Pharmaceuticals
MORE ON THIS TOPIC
IPO
Early-stage Scribe wants to write IPO story even as investors favor derisked portfolios
July 6, 2026
·
2 min read
·
Tristan Manalac
China
AstraZeneca taps China’s CSPC again, betting up to $1.77B to target kidney diseases
July 2, 2026
·
2 min read
·
Tristan Manalac
Deals
Ipsen sends clear Memo to rare diseases with up to $796M buyout
July 1, 2026
·
2 min read
·
Gabrielle Masson
Manufacturing
Eli Lilly and Regeneron among 7 companies picked for FDA PreCheck pilot program
July 1, 2026
·
2 min read
·
Nick Paul Taylor